NCT03509766

Brief Summary

The goal of this study is to compare ten current and readily available FDA approved allergy skin prick devices to determine the most sensitive and specific product and methods used for the diagnosis of allergic disease. The primary outcome will be to determine the analytical sensitivity and specificity of all ten skin prick devices by measuring wheal and flare response to histamine and control diluent in 1mm increments. Secondary outcomes include comparison of skin prick technique, optimum histamine concentration, patient comfort, reproducibility, and the comparability of high-resolution digital images.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2013

Completed
5 days until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

April 26, 2018

Completed
4 months until next milestone

Results Posted

Study results publicly available

August 16, 2018

Completed
Last Updated

August 16, 2018

Status Verified

August 1, 2018

Enrollment Period

1.7 years

First QC Date

December 27, 2013

Results QC Date

May 1, 2018

Last Update Submit

August 14, 2018

Conditions

Keywords

allergicrhinitisallergyasthmafood allergyskin testingskin prick test

Outcome Measures

Primary Outcomes (2)

  • Wheal Response

    Compare Wheal response among devices using 1mm precision. SPT test will be read at 15 min time point. The maximum wheal diameter will be recorded for each of ten skin prick devices. 3mm (and 2mm above negative control) qualify as a positive test.

    15 minutes

  • Sensitivity

    Sensitivity is calculated by dividing the true positive wheals divided by true positives plus false negatives and multiplying by 100. For example one false negative out of 24 tests equals a sensitivity of 95.8%.

    15 minutes

Secondary Outcomes (1)

  • Skin Prick Techniques/Methodology Ratio

    15 minutes

Study Arms (1)

Skin testing

EXPERIMENTAL

All subject both allergic and non-allergic will be tested. There is only one (1) arm.

Device: Histamine skin testing

Interventions

skin testing using histamine

Also known as: skin test device, skin prick test device
Skin testing

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-65 with or without allergic disease

You may not qualify if:

  • severe concurrent illness
  • uncontrolled asthma
  • extensive eczema
  • urticaria
  • dermatographism
  • pregnancy
  • those taking antihistamines within the previous 10 days
  • topical steroids
  • immunomodulatory drugs
  • long term use of oral steroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Hopkins Asthma and Allergy Center

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Rhinitis, AllergicAsthmaFood HypersensitivityRhinitisHypersensitivity

Interventions

Skin Tests

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateImmune System DiseasesBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract InfectionsInfections

Intervention Hierarchy (Ancestors)

Immunologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesImmunologic Techniques

Results Point of Contact

Title
Jody Tversky
Organization
Johns Hopkins School of Medicine

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Neither the subject nor the technician are masked as to which device is being placed. However, the investigator who reads the skin prick test results is blinded as to which device is which.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2013

First Posted

April 26, 2018

Study Start

January 1, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

August 16, 2018

Results First Posted

August 16, 2018

Record last verified: 2018-08

Locations